https://www.selleckchem.com/pr....oducts/a-1155463.htm
Finally, their promise as biomarker of treatment effect and response is also examined.Expert opinion Serum neurofilaments light chain quantification is technically feasible and is likely to provide relevant pieces of information to understand MS pathophysiology, and identify patients at higher risk to develop multiple sclerosis and more severe disability. A future role in monitoring treatment effects and response and drug-related side-effects is envisaged.Recently we evaluated by actigraphy the rest-activity circadian rhythm (RAR) in